Skip to main content

Neurophysiologic evaluation of patients with cervical spondylotic myelopathy



Cervical spondylotic myelopathy (CSM) is a neurodegenerative disease caused by repetitive spinal cord damage that has resulted in significant clinical morbidity. The clinical evaluation of signs and symptoms, as well as neuroimaging and several neurophysiological tests, are used to make the diagnosis.


To investigate changes in the cutaneous silent period (CuSP), cortical silent period (CoSP), and H-reflex in CSM patients, and to correlate these tests with the Japanese Orthopedic Association (JOA) score and Nurick’s grading, as well as to determine the diagnostic value of each of them.


Twenty patients (14 males and 6 females) with CSM were clinically diagnosed and documented by magnetic resonance imaging (MRI), and they were paired with another 20 healthy volunteers (13 males and 7 females) as a control group. CuSP, CoSP, and H-reflex tests were performed on both groups.


In CSM patients, CuSP latency and duration are substantially longer and shorter in CSM patients, respectively. The degree of changes in CuSP latency is well correlated with the severity of the disease. Further, CoSP duration is significantly shortened. The H-reflex parameters did not differ significantly between the patient and control groups.


The shortened CoSP’s duration and the prolonged CuSP's latency suggest malfunction of the inhibitory and excitatory circuits in the spinal cord. The CuSP is more sensitive and specific than the CoSP in the diagnosis of a patient with CSM.


Cervical spondylosis is a degenerative disease that affects the vertebrae, intervertebral disks, facets, and related ligaments. Through direct compression of the spinal cord and/or adjacent blood vessels, the degenerative changes cause cervical spondylotic myelopathy (CSM) [1].

CSM is the most prevalent type of spinal cord injury in adults [2], affecting roughly 100% of individuals with more than 60% canal stenosis [3]. Compressive factors on the spine are involved in the pathophysiology of CSM, which is caused by a mixture of static and dynamic stressors [4].

The clinical sequelae of CSM include a wide range of motor and sensory impairments caused by cervical spinal cord dysfunction [5].

CSM is mostly diagnosed through a combination of history and clinical examination [6]. However, sensory–motor deficits and reflex alterations in the upper limbs are not always present, and physical examination findings are not always consistent with disease severity [7]; in these circumstances, CSM can be mistaken with other degenerative diseases.

Nurick's grading scale [8] and the modified Japanese Orthopedic Association (mJOA) scores [9] were used to determine disease severity. However, according to evaluation standards, there are various issues with JOA ratings, including the fact that they do not represent the patient's self-evaluation of pain, numbness, and health status and they are evaluated solely from the physician's perspective [10].

In these patients, magnetic resonance imaging (MRI) is usually the study of choice since it can show or rule out spinal cord compression. MRI of the spinal cord can detect signal aberrations at the level of cord compression, however it provides no precise information on cervical cord dysfunction in CSM, as radiological data are inconsistent with clinical status in 50% of cases [11].

On the other hand, neuroimaging is not always totally reliable for determining a diagnosis, and MRI cannot assess the functional involvement of the spinal cord. Thus, neurophysiological evaluation by various types of electrodiagnostic procedures may be regarded as a necessary reconcile between clinical assessment and radiographic investigations [12, 13].

The objectives of this study are to study the cutaneous silent period (CuSP), cortical silent period (CoSP), and H-reflex in patients with CSM, to score the sensory and motor deficits using the mJOA score and Nurick's grading, to correlate the different neurophysiological tests with the mJOA score, and to assess the diagnostic utility of each neurophysiological tests.


This is a case–control study conducted from January 2021 to November 2021, at the neurophysiology department of Al-Imamian Al-Kadhemian Medical City, Baghdad. The Iraqi Committee of Medical Specialization approved the study (Decision No. 291; Date 21/1/2021). All subjects who took part in this study gave their consent.

The study included 20 patients of either sex aged 40 to 70 years who have CSM, diagnosed by senior neurosurgeon and documented by MRI. An abductor pollicis brevis (APB) muscle power of grade ≥ 4 according to the Medical Research Council (MRC) scale was ensured for all patients prior to their inclusion in the study.

Patients with a history of cervical surgery, peripheral neuropathy, diabetes, spinal cord lesions, pregnancy, central nervous system disorders, restless leg syndrome, motor neuron disease, fibromyalgia, and epilepsy, brain surgery, the presence of a pacemaker, or any metallic foreign body in the body were all excluded from the study.

The control group consists of another 20 sex- and age-matched healthy volunteers.

Clinical evaluation

The Nurick grading scale and the modified scale of the Japanese Orthopedic Association (mJOA) system were used to assess functional neurological state. Nurick’s grading [8] is as follow: grade 0 = signs and symptoms of root involvement without spinal cord disease; grade 1 = signs of spinal cord disease without difficulty in walking; grade 2 = slight difficulty in walking that does not prevent full-time employment; grade 3 = difficulty in walking that prevents full-time employment or daily takes without requiring assistance with walking; grade 4 = ability to walk only with assistance; and grade 5 = chair bound or bedridden. The lower grades indicating better walking ability.

For the mJOA [9], it is a questionnaire that assesses six functions: motor dysfunction in the upper and lower extremities (0–4), sensory function in the upper and lower extremities (0–2), sensory function in the trunk (0–2), and bladder function (0–3). The sum of these subscales varies from 0 to 17, with a minimum score of 0 being the lowest and a maximum score of 17 being the highest. CSM cores 15–17 for mild, 12–14 for moderate, and 0–11 for severe cases [14].

Cervical spine imaging

A comprehensive radiological evaluation of the cervical spine was performed, which included X-rays to identify spinal cord compressing pathology in the cervical area and MRI with a Siemens (MAGNETOM Aera 1.5T MRI) MRI machine using T1 and T2 sagittal, T2 axial, corono-myelo, sagitto-myelo sections.

Neurophysiological studies

The CuSP and H-reflex measurements were performed using a four-channel electromyography (EMG) equipment (Medtronic, Denmark). Room temperature was monitored between 25 and 28 °C during test procedures and skin temperature between 32 and 34 °C was ensured using a skin thermometer.

For the CuSP, ring electrodes were applied to stimulate the index finger, and EMG activity was recorded using surface electrodes from the APB with filter setting of 2 Hz–10 kHz.

Participants were asked to make an opposition of the right thumb to obtain a steady maximal contraction, and an EMG audiosignal was used to monitor muscle contraction. A single painful stimulus (80-mA intensity) with a 0.5-ms duration was delivered to the index finger during maximal voluntary contraction until a complete silent period of consistent latency and duration was attained. The experiment was repeated at least ten times until we obtained five ideal recordings demonstrating total silence of the motor unit potential with the longest duration and shortest delay.

We chose the mean value of the five best CuSPs as the final value for CuSP parameters in each subject to reduce any variation in CuSP parameters. The interval between stimulation and the start of the silent period was characterized as CuSP latency. The time between the start and end of the silent period was specified as CuSP duration. Visual assessment at the start of an abrupt reduction or upon recovery of EMG activity determined the onset and endpoint latencies of each CuSP [15].

To measure H-reflex, participants were sitting comfortably with their forearms on a table in front of them. Surface recording electrodes were used to capture the H-reflex of the flexor carpi radialis. The active electrode was put over the flexor carpi radialis muscle belly, and the reference electrode was placed over the brachioradialis, away from other forearm median-innervated muscles. A bipolar felt pad electrode was used to stimulate the median nerve just proximal to the elbow (cathode proximal, pulse width 0.5 ms). The ground electrode lies between the stimulator and the recording electrode [16].

Responses to median nerve stimulation were identified as H-reflexes if they had latencies between 12 and 25 ms. Five H-responses were analyzed to ensure that they were repeatable. After correcting for height (or limb length), latencies were determined from the onset of stimulus artifact until the start of the reflex response. The amplitudes were measured from the baseline to the highest negative peak and H/M amplitude ratio was calculated.

An EMG equipment (Micromed, Italy) was used for CoSP. Each participant sat on a comfortable chair. Three brief maximal voluntary isometric contractions (5 s) starting off the test. To avoid exhaustion, maximum efforts were spaced by approximately 60 s of rest. The subjects next performed isometric contractions, which resulted in the firing of one or two single motor units that could be identified.

The appropriate region of the hemisphere for APB muscle was stimulated with a transcranial magnetic stimulator (Magstim 2002, Magstim Co., Whitland, UK) using circular coil electrode with a 90-mm diameter (type 9784, UK). The stimulation site on the head was determined utilizing suprathreshold stimuli around the C3 region, as per the international 10–20 system [17].

During a weak isometric contraction of the contralateral APB muscle, five to ten random (between 4 and 6 s) single pulse transcranial magnetic stimulation at an intensity of roughly 140% of resting motor threshold were applied. The best location was then identified and used throughout the experiment [18].

To reduce variability, the individual was requested to maximally contract the APB muscle against resistance, then a single suprathreshold transcranial magnetic stimulation pulse was given to the motor cortex, followed by at least five repeatable responses. We looked for motor evoked potentials (MEPs) with the shortest latency and maximum amplitude. The duration of CoSP is measured from the start of muscle activity suppression to the return of muscle activity. 30-Hz low filter and 30-kHz high filter settings were employed.

Statistical analysis

For all statistical studies, statistical package of social sciences (SPSS) software version 25.0 was utilized (SPSS, Chicago). Continuous data were expressed as mean ± SD and analyzed with a Student’s t-test (between two groups) or an analysis of variance with least significant difference as a post hoc pairwise comparison (between more than two groups).

Categorical variables were expressed as numbers and percentages. The receiver operating characteristic curve was used to find out the discriminative value of some parameters to differentiate between patients and controls. The possible association of neurophysiological measures with age, disease duration, arm length, and JOA score was investigated using Pearson's correlation test. When the p-value was less than 0.05, the difference was considered statistically significant.


Demographic data

Table 1 shows the demographic data of the study population. There was no significant difference between the patients and the control groups in terms of age, gender, or occupation.

Table 1 Demographic data of the study population

Regarding the patients' clinical characteristics, all of them had progressing myelopathy with varied degrees of decreased sensorimotor function in both the upper and lower extremities, as well as bladder dysfunction. Table 2 shows that the mean disease duration was 20.1 months (range: 6–84 months). According to the mJOA score, seven patients (35%) had mild disabilities, eight (40%) had moderate disabilities, and five (25%) had severe disabilities. According to Nurick’s grading, 2% of the patients were in grade 1, 10% in grade II, 7% in grade III, and the remaining 5% in grade IV.

Table 2 Clinical characteristics of the patients

All 20 individuals had pathologic abnormalities on their cervical MRIs. C3–C4 compression was seen in four (20%) patients, C4–C5 compression in four (20%) patients, C5–C6 compression in nine (45%) patients, and C6–C7 compression in three (15%) patients.

Neurophysiological data

Three patients, one with severe disability (mJOA score = 0–11), and two with moderate disability (mJOA = 12–14), had absent H-reflex. The neurophysiological data of the study population are shown in Table 3. CuSP onset in the CSM group was 82.9 ± 15.45 mesc which is considerably longer than 77.04 ± 8.27 ms of the control group (p = 0.008). CuSP on the other hand, has a duration of 32.72 ± 7.27 ms which is significantly less than 46.37 ± 5.43 ms of the control group (p < 0.001).

Table 3 Comparison of neurophysiological data in the study population

Moreover, the duration of CoSP of the patient group equals 53.28 ± 14.35 ms which was also shorter than 86.13 ± 20.79 ms of the control group (p < 0.001). The onset of CoSP, on the other hand, did not differ among the groups studied (p = 0.953). Likewise, there was no difference in H-reflex latency or H/M amplitude ratio between the two groups (p = 0.075; p = 0.154), respectively.

As indicated in Table 4, no significant correlation was found between the various neurophysiological variables and any of the different parameters of patients (such as age, disease duration, arm length, and mJOA score).

Table 4 Correlation of neurophysiological tests with other variables in the patient group

Table 5 shows that gender was significantly associated with the H/M amplitude ratio being higher in males than females (p = 0.046) when testing for a possible association between the dichotomous factors and neurophysiological parameters (if any) within the patient group. In addition, the onset of CuSP was correlated with Nurick grade IV (p = 0.011). Furthermore, the CuSP duration was shown to be associated with the C6-7 MRI lesion site (p = 0.037).

Table 5 Association of neurophysiological tests with dichotomous variables in the patient group

The diagnostic values of CuSP onset, CuSP duration, and CoSP duration in the context of discrimination between patients and controls were determined using the receiver operating characteristic curve. The area under the curve (AUC) for CuSP onset was 0.754, 95% CI 0.597–0.911, p = 0.006. At a cut-off value of CuSP onset = 73.9 ms, the test’s sensitivity and specificity were 75% and 65%, respectively, as shown in Fig. 1.

Fig. 1
figure 1

Receiver operating characteristic curve for CuSP onset in the context of discrimination between patients and controls

The AUC for CuSP duration was 0.943, 95% CI 0.856–1.0, p < 0.001. At a cut-off value of CuSP duration = 40.4 ms, the test's sensitivity and specificity were 80% and 90%, respectively. The AUC for CoSP duration was 0.903, 95% CI 0.813–0.992, p < 0.001. At a cut-off value of CoSP duration = 69.5 ms, the test's sensitivity and specificity were both 80% as shown in Fig. 2.

Fig. 2
figure 2

Receiver operating characteristic curve for CuSP duration and CoSP duration in the context of discrimination between patients and controls


The natural course of CSM is quite variable. Although myelopathic signs are an integral component of clinical diagnosis of CSM, however, they are not very sensitive and may be absent in about 20% of myelopathic patients. Thus, signal changes on MRI and some electrophysiological tests are valuable adjuncts to diagnosis. In general, our study demonstrates significant changes in the CuSP latency and duration and CoSP duration, whereas, the H-reflex parameters did not differ between the patient and control groups.

The failure to record a significant difference in H-reflex parameters between patients with CSM and controls could be due to the fact that nearly half of the patients tested had MRI lesions above the C5 spinal segment. Cervical radiculopathies, which affect the C7, C6, C8, and C5 nerve roots, are thought to account for only 5–10% of all spinal nerve root disorders [19, 20]. For patients with C6/7 [21, 22] or C7 [23], an upper extremity H-reflex study (mediated through C6/C7 levels through the median nerve measured across the flexor carpi radialis muscle) is recommended.

Men had higher H/M values than women in this study, which could indicate that women had lower motoneuron excitability during H-reflex evaluations. Mendonca and his colleagues came to a similar conclusion [24]. Other literatures on the issue found discrepancies in the interaction between sex and the H/M ratio [25,26,27,28].

Dissimilarities at this level may be related to methodological concerns, despite the fact that the exact mechanisms are unknown. Because of its modulation by various well-known factors [29, 30] or sex-related changes in brain maturation [31], as well as differential activation of cortical areas during motor tasks [31, 32], H-reflex recordings require very precise and constrained conditions.

MRI is beneficial for identifying SC compression and intramedullary signal alterations, although morphological abnormalities do not always correspond to clinical signs and symptoms [33]. As a result, the CuSP was used in this study since its anomaly indicates intramedullary pathology such CSM and syringomyelia [34, 35]. Furthermore, even if the aberration is mild, it is said to be able to detect CSM [36].

Patients with CSM had significantly different CuSP parameters than the control group in this study. These findings are also consistent with what other study groups have found [34,35,36,37,38]. CuSP abnormalities could be explained by structural alterations in neurons and axons caused by aberrant signal processing in the spinal cord [39]. CuSP is mediated by a spinal inhibitory reflex that is subject to supraspinal descending control, which supports this theory [39, 40].

Leis and coworkers [41] found that cervical radiculopathy is not associated with the absence or delay of the CuSP, claiming that the smaller, slower conducting A-delta fibers are relatively less affected by injury or disease that may significantly impair conduction along large afferent fibers, which is supported by previous findings that indicate differential involvement of small versus large fibers in several related peripheral NS conditions.

CuSP duration was considerably shorter in patients with C6-7 compression site compared to other compression sites (as shown in Tables 3, 4). This is because the APB muscle and the index fingertip were thought to represent the cervical 6 and 7 dermatomes, as well as the cervical 8 and thoracic 1 myotome [42]. Tadokoro and colleagues also detected significant involvement of the lower and middle cervical regions [38]. This is corroborated by the findings of Stetkarova and colleagues [35] who found normal CuSP in patients with CSM at the C3–C4 intervertebral disc level and by the findings of Kofler and colleagues [40] who found normal CuSP in patients with thoracic myelopathy.

Furthermore, Tables 3, 4 show that there is an association between disease severity as measured by the Nurick's classification and CuSP latency prolongation. Patients who are allowed to progress to Nurick grade 4 are unlikely to make a complete recovery and are unlikely to improve with surgical intervention [43]. This indicated that the more structural abnormalities in the spinal cord, the worse the functional impairment and the longer the CuSP onset latency. Patients with more severe cases of CSM (including gait alterations) exhibit more significant CuSP abnormalities, according to Lo and colleagues [36].

In this study’s CoSP, the duration but not the latency was altered in patients with CSM. Suyama and coworkers [44] and Nicotra and associates [45] both found similar findings. Increased cortical or spinal segmental excitability could be the cause of this shortening [46]. The decreased activity of GABAergic inhibitory interneurons that moderate corticomotoneuronal output is likely to be responsible for the increased intracortical excitability [47].

In comparison to CuSP onset latency and CoSP duration, CuSP duration has the highest sensitivity and specificity. To the best of our knowledge, no comparable findings were present in the literature. CuSP parameters were considerably altered in CSM patients, which is consistent with findings from earlier studies [35,36,37,38, 48]. Studies have demonstrated that measuring the CuSP can provide information beyond that obtained from MEPs induced with TMS in cervical cord lesions due to its relevance in SC lesions. CuSP, mediated by spinal reflexes with supraspinal descending control, may address a larger anatomical circuit or area comprising afferent, efferent, and supraspinal inputs, as evidenced in CSM lesions as a result of disc protrusion and anterior cord indentation [36, 37].

The CuSP was not tested following corrective surgery to further assess its validity in patients with CSM, which is one of the study's limitations plus the small sample size.


Our study concludes that CuSP is an effective quick and noninvasive tool for evaluating CSM. CuSP and CoSP electrophysiological changes point to a dysfunction with the inhibitory and excitatory circuits at a spinal level. In the diagnosis of a patient with CSM, CuSP is more sensitive and specific than CoSP.

Availability of data and materials

All data generated or analyzed during this study are included in this published article. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Abductor pollicis brevis


Area under the curve


Cortical silent period


Cervical spondylotic myelopathy


Cutaneous silent period




Modified Japanese Orthopedic Association


Magnetic resonance imaging


  1. Bakhsheshian J, Mehta VA, Liu JC. Current diagnosis and management of cervical spondylotic myelopathy. Global Spine J. 2017;7(6):572–86.

    Article  Google Scholar 

  2. Iyer A, Azad TD, Tharin S. Cervical spondylotic myelopathy. Clin Spine Surg. 2016;29(10):408–14.

    Article  Google Scholar 

  3. Nouri A, Montejo J, Sun X, Virojanapa J, Kolb LE, Abbed KM, et al. Cervical cord-canal mismatch: a new method for identifying predisposition to spinal cord injury. World Neurosurg. 2017;108:112–7.

    Article  Google Scholar 

  4. Nandyala S, Khanna A, Hassanzadeh H. Pathophysiology, natural history, and clinical syndromes of cervical disc disease. In: Garfin S, Eismont F, Bell G, Bono C, Fischgrund J, editors. Rothman-Simeone and Herkowitz’s the spine. 7th ed. Philadelphia: Elsevier, Inc.; 2018. p. 677–87.

    Google Scholar 

  5. Lebl DR, Hughes A, Cammisa FP Jr, O’Leary PF. Cervical spondylotic myelopathy: pathophysiology, clinical presentation, and treatment. HSS J. 2011;7(2):170–8.

    Article  Google Scholar 

  6. McCormick JR, Sama AJ, Schiller NC, Butler AJ, Donnally CJ 3rd. Cervical spondylotic myelopathy: a guide to diagnosis and management. J Am Board Fam Med. 2020;33(2):303–13.

    Article  Google Scholar 

  7. Al-Mefty O, Harkey LH, Middleton TH, Smith RR, Fox JL. Myelopathic cervical spondylotic lesions demonstrated by magnetic resonance imaging. J Neurosurg. 1988;68(2):217–22.

    Article  CAS  Google Scholar 

  8. Zileli M, Borkar SA, Sinha S, Reinas R, Alves ÓL, Kim SH, et al. Cervical spondylotic myelopathy: natural course and the value of diagnostic techniques—WFNS Spine Committee Recommendations. Neurospine. 2019;16(3):386–402.

    Article  Google Scholar 

  9. Donnally CJ 3rd, Butler AJ, Rush AJ 3rd, Bondar KJ, Wang MY, Eismont FJ. The most influential publications in cervical myelopathy. J Spine Surg. 2018;4(4):770–9.

    Article  Google Scholar 

  10. Kasai Y, Fukui M, Takahashi K, Wojtys EM, Murtaugh P. Verification of the sensitivity of functional scores for treatment results—substantial clinical benefit thresholds for the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ). J Orthop Sci. 2017;22(4):665–9.

    Article  Google Scholar 

  11. Nové-Josserand A, André-Obadia N, Mauguière F. Cervical spondylotic myelopathy: motor and somatosensory evoked potentials, clinical and radiological correlation. Rev Neurol. 2002;158(12 Pt 1):1191–7.

    Google Scholar 

  12. Nardone R, Höller Y, Thomschewski A, Höller P, Bergmann J, Golaszewski S, et al. Central motor conduction studies in patients with spinal cord disorders: a review. Spinal cord. 2014;52:420–7.

    Article  CAS  Google Scholar 

  13. Severino R, Nouri A, Tessitore E. Degenerative cervical myelopathy: how to identify the best responders to surgery? J Clin Med. 2020;9(3):759.

    Article  Google Scholar 

  14. Cheng XJ, Jin L, Wang X, Zhang W, Shen Y. Predictors of poor outcome in cervical spondylotic myelopathy patients underwent anterior hybrid approach: focusing on change of local kyphosis. J Orthop Surg Res. 2020;15:369.

    Article  Google Scholar 

  15. Tiric-Campara M, Denislic M, Djelilovic-Vranic J, Alajbegovic A, Tupkovic E, Gojak R, et al. Cutaneous silent period in the evaluation of small nerve fibres. Med Arch. 2014;68(2):98–101.

    Article  Google Scholar 

  16. Dumitru D, Amato AA, Zwartz MJ. Nerve conduction studies. In: Dumitru D, Amato AA, Zwarts MJ, editors. Electrodiagnostic medicine. 2nd ed. Philadelphia: Hanley & Belfus; 2002. p. 195.

    Google Scholar 

  17. Herwig U, Satrapi P, Schönfeldt-Lecuona C. Using the International 10–20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16(2):95–9.

    Article  Google Scholar 

  18. Edwardson MA, Avery DH, Fetz EE. Volitional muscle activity paired with transcranial magnetic stimulation increases corticospinal excitability. Front Neurosci. 2015;8:442.

    Article  Google Scholar 

  19. Wilbourn AJ, Aminoff MJ. Radiculopathies. In: Brown WF, Bolton CF, editors. Clinical electromyography. 2nd ed. Boston: Butterworth-Heinemann; 1993. p. 177–209.

    Google Scholar 

  20. Wilbourn AJ, Aminoff MJ. American Association of Electrodiagnostic Medicine minimonograph 32: the electrodiagnostic examination in patients with radiculopathies. Muscle Nerve. 1998;21(12):1612–6.;2-0.

    Article  CAS  Google Scholar 

  21. White JC. The ubiquity of contraction enhanced H reflex: normative data and use in the diagnosis of radiculopathies. Electroencephalogr Clin Neurophysiol. 1991;81(6):433–42.

    Article  CAS  Google Scholar 

  22. Eliaspour D, Sanati E, Hedayati Moqadam MR, Rayegani SM, Bahrami MH. Utility of flexor carpi radialis h-reflex in diagnosis of cervical radiculopathy. J Clin Neurophysiol. 2009;26(6):458–60.

    Article  Google Scholar 

  23. Zheng C, Zhu Y, Lv F, Ma X, Xia X, Wang L, et al. Abnormal flexor carpi radialis H-reflex as a specific indicator of C7 as compared with C6 radiculopathy. J Clin Neurophysiol. 2014;31(6):529–34.

    Article  Google Scholar 

  24. Mendonca GV, Pezarat-Correia P, Gonçalves AD, Gomes M, Correia JM, Vila-Chã C. Sex differences in soleus muscle H-reflex and V-wave excitability. Exper Physiol. 2020;105(11):1928–38.

    Article  CAS  Google Scholar 

  25. Hoffman M, Norcross M, Johnson S. The Hoffmann reflex is different in men and women. NeuroReport. 2017;29(4):314–6.

    Article  Google Scholar 

  26. Johnson ST, Kipp K, Hoffman MA. Spinal motor control differences between the sexes. Eur J Appl Physiol. 2012;112(11):3859–64.

    Article  Google Scholar 

  27. Hoffman MA, Doeringer JR, Norcross MF, Johnson ST, Chappell PE. Presynaptic inhibition decreases when estrogen level rises. Scand J Med Sci Sports. 2018;28(9):2009–15.

    Article  CAS  Google Scholar 

  28. Hoffman M, Harter RA, Hayes BT, Wojtys EM, Murtaugh P. The interrelationships among sex hormone concentrations, motoneuron excitability, and anterior tibial displacement in women and men. J Athlet Train. 2008;43(4):364–72.

    Article  Google Scholar 

  29. Zehr EP. Considerations for use of the Hoffmann reflex in exercise studies. Eur J Appl Physiol. 2002;86(6):455–68.

    Article  Google Scholar 

  30. Knikou M. The H-reflex as a probe: pathways and pitfalls. J Neurosci Methods. 2008;171(1):1–12.

    Article  Google Scholar 

  31. Lenroot RK, Gogtay N, Greenstein DK, Wells EM, Wallace GL, Clasen LS, et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage. 2007;36(4):1065–73.

    Article  Google Scholar 

  32. Lissek S, Hausmann M, Knossalla F, Peters S, Nicolas V, Güntürkün O, et al. Sex differences in cortical and subcortical recruitment during simple and complex motor control: an fMRI study. Neuroimage. 2007;37(3):912–26.

    Article  Google Scholar 

  33. Kato F, Yukawa Y, Suda K, Yamagata M, Ueta T. Normal morphology, age-related changes and abnormal findings of the cervical spine. Part II: magnetic resonance imaging of over 1,200 asymptomatic subjects. Eur Spine J. 2012;21(8):1499–507.

    Article  Google Scholar 

  34. Roser F, Ebner FH, Liebsch M, Dietz K, Tatagiba M. A new concept in the electrophysiological evaluation of syringomyelia. J Neurosurg Spine. 2008;8(6):517–23.

    Article  Google Scholar 

  35. Stetkarova I, Kofler M. Cutaneous silent periods in the assessment of mild cervical spondylotic myelopathy. Spine. 2009;34(1):34–42.

    Article  Google Scholar 

  36. Lo YL, Tan YE, Dan YF, Leoh TH, Tan SB, Tan CT, et al. Cutaneous silent periods in the evaluation of cord compression in cervical spondylosis. J Neurol. 2007;254(1):141–9.

    Article  Google Scholar 

  37. Nardone R, Höller Y, Brigo F, Frey VN, Lochner P, Leis S, et al. The contribution of neurophysiology in the diagnosis and management of cervical spondylotic myelopathy: a review. Spinal Cord. 2016;54(10):756–66.

    Article  CAS  Google Scholar 

  38. Tadokoro N, Kiyasu K, Kasai Y, Kawasaki M, Takemasa R, Ikeuchi M. Discrepancy between functional recovery and cutaneous silent period change in surgically treated degenerative cervical myelopathy: a prospective pilot study. Spinal Cord. 2019;57:1076–83.

    Article  Google Scholar 

  39. Logigian EL, Plotkin GM, Shefner JM. The cutaneous silent period is mediated by spinal inhibitory reflex. Muscle Nerve. 1999;22(4):467–72.;2-y.

    Article  CAS  Google Scholar 

  40. Kofler M, Kronenberg MF, Brenneis C, Felber A, Saltuari L. Cutaneous silent periods in intramedullary spinal cord lesions. J Neurol Sci. 2003;216(1):67–79.

    Article  Google Scholar 

  41. Leis AA, Kofler M, Stetkarova I, Stokic DS. The cutaneous silent period is preserved in cervical radiculopathy: significance for the diagnosis of cervical myelopathy. Eur Spine J. 2011;20(2):236–9.

    Article  Google Scholar 

  42. Chiba T, Konoeda F, Higashihara M, Kamiya H, Oishi C, Hatanaka Y, et al. C8 and T1 innervation of forearm muscles. Clin Neurophysiol. 2015;126(4):837–42.

    Article  Google Scholar 

  43. Pumberger M, Froemel D, Aichmair A, Hughes AP, Sama AA, Cammisa FP, et al. Clinical predictors of surgical outcome in cervical spondylotic myelopathy. Bone Joint J. 2013;95(7):966–71.

    Article  Google Scholar 

  44. Suyama N, Shindo H, Iizuka T. Study of the silent period following motor evoked potential by magnetic stimulation method. J Orthop Sci. 1996;1(5):301–6.

    Article  Google Scholar 

  45. Nicotra A, King NKK, Catley M, Mendoza N, McGregor AH, Strutton PH. Evaluation of corticospinal excitability in cervical myelopathy, before and after surgery, with transcranial magnetic stimulation: a pilot study. Eur Spine J. 2013;22(1):189–96.

    Article  Google Scholar 

  46. Sfreddo HA, Wecht JR, Alsalman O, Wu YK, Harel NY. Duration and reliability of the silent period in individuals with spinal cord injury. Spinal Cord. 2021;59(8):885–93.

    Article  Google Scholar 

  47. Raffaele N. Enhanced motor cortex excitability after spinal cord injury. Neural Regen Res. 2015;10(12):1943–4.

    Article  Google Scholar 

  48. Tadokoro N, Kiyasu K, Kasai Y, Kawasaki M, Takemasa R, Ikeuchi M. Relationship between cutaneous silent period characteristics and lesion site in the cervical spinal cord. J Spine Neurosurg. 2017;6(4):1–4.

    Article  Google Scholar 

Download references


We thank assistant professor Dr. Qasim Al-Mayah from the Research Medical Unit/College of Medicine/Al-Nahrain University for helping in statistical analysis.


This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations



All the authors have directly participated in the preparation of this manuscript and have approved the final version submitted. ‘IN’ clinically examined and referring patients with cervical spondylotic myelopathy. ‘ZJ’ and ‘FH’ did the electrodiagnostic tests. ‘FH’ and ‘ZJ’ drafted the manuscript. ‘ZJ’, ‘IN', and ‘FH’ conceived the study and participated in its design and interpretation. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Farqad B. Hamdan.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Iraqi Board for Medical Specialization (Decision No. 291; Date 21/1/2021). Written consent for participation from all subjects was ensured.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jawad, Z.Y., Hamdan, F.B. & Nema, I.S. Neurophysiologic evaluation of patients with cervical spondylotic myelopathy. Egypt J Neurol Psychiatry Neurosurg 58, 166 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: